BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 18321582)

  • 1. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.
    Friedman DS; Hahn SR; Gelb L; Tan J; Shah SN; Kim EE; Zimmerman TJ; Quigley HA
    Ophthalmology; 2008 Aug; 115(8):1320-7, 1327.e1-3. PubMed ID: 18321582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician beliefs and behaviors related to glaucoma treatment adherence: the Glaucoma Adherence and Persistency Study.
    Gelb L; Friedman DS; Quigley HA; Lyon DW; Tan J; Kim EE; Zimmerman TJ; Hahn SR
    J Glaucoma; 2008 Dec; 17(8):690-8. PubMed ID: 19092468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
    Quigley HA; Friedman DS; Hahn SR
    Ophthalmology; 2007 Sep; 114(9):1599-606. PubMed ID: 17572498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice.
    Friedman DS; Hahn SR; Quigley HA; Kotak S; Kim E; Onofrey M; Eagan C; Mardekian J
    Ophthalmology; 2009 Dec; 116(12):2277-85.e1-3. PubMed ID: 19744715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).
    Friedman DS; Quigley HA; Gelb L; Tan J; Margolis J; Shah SN; Kim EE; Zimmerman T; Hahn SR
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5052-7. PubMed ID: 17962457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension.
    Flowers B; Wand M; Piltz-Seymour J; Berke SJ; Day D; Teague J; Smoot TM; Landry TA; Bergamini MV; Mallick S;
    Clin Ther; 2006 Nov; 28(11):1803-11. PubMed ID: 17213000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence and adherence with topical glaucoma therapy.
    Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM
    Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health literacy and adherence to glaucoma therapy.
    Muir KW; Santiago-Turla C; Stinnett SS; Herndon LW; Allingham RR; Challa P; Lee PP
    Am J Ophthalmol; 2006 Aug; 142(2):223-6. PubMed ID: 16876500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
    Rees G; Leong O; Crowston JG; Lamoureux EL
    Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of adherence to glaucoma medical therapy in a long-term patient population.
    Djafari F; Lesk MR; Harasymowycz PJ; Desjardins D; Lachaine J
    J Glaucoma; 2009 Mar; 18(3):238-43. PubMed ID: 19295380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-centered communication to assess and enhance patient adherence to glaucoma medication.
    Hahn SR
    Ophthalmology; 2009 Nov; 116(11 Suppl):S37-42. PubMed ID: 19837259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glaucoma research foundation patient survey: patient understanding of glaucoma and its treatment.
    Herndon LW; Brunner TM; Rollins JN
    Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S22-7. PubMed ID: 16389057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
    Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
    Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims.
    Copher R; Buzinec P; Zarotsky V; Kazis L; Iqbal SU; Macarios D
    Curr Med Res Opin; 2010 Apr; 26(4):777-85. PubMed ID: 20095797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported behavior and problems in using glaucoma medications.
    Sleath B; Robin AL; Covert D; Byrd JE; Tudor G; Svarstad B
    Ophthalmology; 2006 Mar; 113(3):431-6. PubMed ID: 16458967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beliefs about medicines and adherence among Swedish migraineurs.
    Hedenrud T; Jonsson P; Linde M
    Ann Pharmacother; 2008 Jan; 42(1):39-45. PubMed ID: 18073328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of patient-centered communication training on discussion and detection of nonadherence in glaucoma.
    Hahn SR; Friedman DS; Quigley HA; Kotak S; Kim E; Onofrey M; Eagan C; Mardekian J
    Ophthalmology; 2010 Jul; 117(7):1339-47.e6. PubMed ID: 20207417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.